There’s no legal precedent to know how courts will view an institution’s response to a student or employee refusing a COVID-19 vaccine under emergency-use status.
Losses that triggered the liquidation of positions approaching $30 billion in value bring to light complicated financial instruments used by European investors that are effectively banned in the U.S. but could still have spillover effects domesticall...